Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHREE GANESH REMEDIES vs BETA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHREE GANESH REMEDIES BETA DRUGS SHREE GANESH REMEDIES /
BETA DRUGS
 
P/E (TTM) x 30.4 - - View Chart
P/BV x 7.1 12.8 55.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SHREE GANESH REMEDIES    BETA DRUGS
EQUITY SHARE DATA
    SHREE GANESH REMEDIES
Mar-24
BETA DRUGS
Mar-24
SHREE GANESH REMEDIES /
BETA DRUGS
5-Yr Chart
Click to enlarge
High Rs7361,595 46.1%   
Low Rs246645 38.1%   
Sales per share (Unadj.) Rs92.0307.7 29.9%  
Earnings per share (Unadj.) Rs20.537.9 54.2%  
Cash flow per share (Unadj.) Rs25.048.1 52.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs89.2163.5 54.6%  
Shares outstanding (eoy) m13.699.61 142.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.33.6 146.6%   
Avg P/E ratio x23.929.5 80.9%  
P/CF ratio (eoy) x19.623.3 84.3%  
Price / Book Value ratio x5.56.9 80.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m6,71710,765 62.4%   
No. of employees `000NANA-   
Total wages/salary Rs m84201 41.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,2592,957 42.6%  
Other income Rs m3114 212.9%   
Total revenues Rs m1,2902,972 43.4%   
Gross profit Rs m418599 69.8%  
Depreciation Rs m6198 62.5%   
Interest Rs m628 21.5%   
Profit before tax Rs m382488 78.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101123 81.6%   
Profit after tax Rs m281364 77.1%  
Gross profit margin %33.220.3 163.9%  
Effective tax rate %26.325.3 104.3%   
Net profit margin %22.312.3 181.2%  
BALANCE SHEET DATA
Current assets Rs m7751,876 41.3%   
Current liabilities Rs m260944 27.5%   
Net working cap to sales %40.931.5 129.8%  
Current ratio x3.02.0 150.2%  
Inventory Days Days2313 181.9%  
Debtors Days Days589978 60.3%  
Net fixed assets Rs m1,007748 134.6%   
Share capital Rs m12896 133.6%   
"Free" reserves Rs m1,0931,475 74.1%   
Net worth Rs m1,2211,571 77.7%   
Long term debt Rs m29160 482.0%   
Total assets Rs m1,7822,624 67.9%  
Interest coverage x63.918.3 349.2%   
Debt to equity ratio x0.20 620.3%  
Sales to assets ratio x0.71.1 62.7%   
Return on assets %16.115.0 107.7%  
Return on equity %23.023.2 99.3%  
Return on capital %25.631.6 81.1%  
Exports to sales %50.115.0 333.1%   
Imports to sales %12.50.4 3,551.5%   
Exports (fob) Rs m631445 141.8%   
Imports (cif) Rs m15710 1,512.5%   
Fx inflow Rs m631445 141.8%   
Fx outflow Rs m15741 382.1%   
Net fx Rs m474404 117.4%   
CASH FLOW
From Operations Rs m304309 98.4%  
From Investments Rs m-330-140 236.3%  
From Financial Activity Rs m98-75 -131.4%  
Net Cashflow Rs m7295 76.0%  

Share Holding

Indian Promoters % 70.5 66.7 105.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.3 0.8%  
FIIs % 0.0 1.2 0.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 33.3 88.7%  
Shareholders   8,508 2,567 331.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHREE GANESH REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on SHREE GANESH REMEDIES vs BETA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SHREE GANESH REMEDIES vs BETA DRUGS Share Price Performance

Period SHREE GANESH REMEDIES BETA DRUGS S&P BSE HEALTHCARE
1-Day 0.48% 5.14% 1.23%
1-Month -12.19% 5.14% -0.24%
1-Year 7.04% 5.14% 43.62%
3-Year CAGR 25.97% 1.68% 20.35%
5-Year CAGR 59.99% 1.01% 26.24%

* Compound Annual Growth Rate

Here are more details on the SHREE GANESH REMEDIES share price and the BETA DRUGS share price.

Moving on to shareholding structures...

The promoters of SHREE GANESH REMEDIES hold a 70.5% stake in the company. In case of BETA DRUGS the stake stands at 66.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SHREE GANESH REMEDIES and the shareholding pattern of BETA DRUGS .

Finally, a word on dividends...

In the most recent financial year, SHREE GANESH REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BETA DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SHREE GANESH REMEDIES , and the dividend history of BETA DRUGS .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.